This Article Full Text Full Text (PDF) All Versions of this Article: 92/6/2346    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Palming, J. Articles by Carlsson, L. M. S. Search for Related Content PubMed PubMed Citation Articles by Palming, J. Articles by Carlsson, L. M. S. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Medline Plus Health Information Liver Diseases Nutrition Obesity Related Collections Diabetes and Insulin Metabolism Obesity

The Expression of NAD(P)H:Quinone Oxidoreductase 1 Is High in Human Adipose Tissue, Reduced by Weight Loss, and Correlates with Adiposity, Insulin Sensitivity, and Markers of Liver Dysfunction

Sahlgrenska Center for Cardiovascular and Metabolic Research (J.P., K.S., M.J., T.C.L., A.G., B.C., L.M.S.C.), Department of Molecular and Clinical Medicine (M.L.), and Department of Radiology (L.L.), the Sahlgrenska Academy, Göteborg University, SE-413 45 Göteborg, Sweden; and Donald W. Reynolds Cardiovascular Clinical Research Center (S.R.), University of Texas Southwestern Medical Center, Dallas, Texas 75390

Address all correspondence and requests for reprints to: Kajsa Sjöholm, Vita Stråket 15, SE-413 45 Göteborg, Sweden. E-mail: kajsa.sjoholm{at}medic.gu.se.

Context: We have previously identified nicotinamide adenine dinucleotide phosphate:quinone oxidoreductase 1 (NQO1), an enzyme involved in the protection against oxidative stress, as a gene predominantly expressed in human adipocytes. Studies in mice deficient in NQO1 activity suggest that NQO1 may also play an important role in metabolism.

Objective: The aim of this study was to explore the expression and regulation of NQO1 in human adipose tissue (AT) and isolated adipocytes.

Patients and Results: The high expression of NQO1 in adipocytes was verified in human adipocytes and AT by real-time PCR. DNA microarray analysis showed that NQO1 was expressed at higher levels in large compared with small adipocytes, isolated from the same fat biopsy. Furthermore, NQO1 mRNA levels were positively correlated with adipocyte size (n = 7; P < 0.002). During an 18-wk diet regime (n = 24; mean weight loss 27 kg), the NQO1 expression in human sc AT was down-regulated (P < 0.0001), and mRNA levels correlated with body mass index (P = 0.0005), sc, and total abdominal AT areas, as determined by computerized tomography (P < 0.0001, both) and metabolic parameters. NQO1 mRNA levels were also positively correlated with aspartate aminotransferase (P = 0.0028) and alanine aminotransferase (P = 0.0219), markers known to be associated with severity of hepatic steatosis.

Conclusions: NQO1 is highly expressed in human AT, particularly in large adipocytes. AT NQO1 expression is reduced during diet-induced weight loss, and the expression levels positively correlate with adiposity, glucose tolerance, and markers of liver dysfunction. Together, these findings indicate a role for NQO1 in the metabolic complications of human obesity.

This article has been cited by other articles:

				A. Gummesson, M. Jernas, P.-A. Svensson, I. Larsson, C. A. M. Glad, E. Schele, L. Gripeteg, K. Sjoholm, T. C. Lystig, L. Sjostrom, et al. Relations of Adipose Tissue CIDEA Gene Expression to Basal Metabolic Rate, Energy Restriction, and Obesity: Population-Based and Dietary Intervention Studies J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4759 - 4765. [Abstract] [Full Text] [PDF]